AstraZeneca’s Imfinzi approved in the US for endometrial cancer
US approval for endometrial cancer drugLeads to 58% improvement in survival ratesImfinzi generated sales of $4.2 billionPharmaceutical giant AstraZeneca (AZN) said it has received US regulatory approval for its cancer drug Imfinzi...
17 June 2024